Table 2.
Mean age | Females | Current smoking | Hypertension | Diabetes mellitus | eGFR <60 ml/min/1.73m2 | History of stroke or TIA | History of ACS | Antiplatelet therapy | Statin therapy | Beta-blocker therapy | |
---|---|---|---|---|---|---|---|---|---|---|---|
CONVINCE | 66.3 ± 10.0 | 30.5% | 22.1% | 65.4% | 22.3% | NA | 100% | 9% | 97.5% | 93.5% | NA |
LoDoCo2 | 65.8 ± 8.6 | 15.3% | 11.8% | 50.9% | 18.3% | 5.5% | 4.0% | 84.4% | 90.9% | 94.0% | 62.1% |
COPS | 59.9 ± 10.3 | 20.8% | 34.8% | 50.3% | 19.0% | NA | 2.0% | 100% | 98.6% | 98.9% | 82.6% |
COLCOT | 60.6 ± 10.7 | 19.2% | 29.9% | 51.0% | 20.2% | NA | 2.6% | 100% | 98.8% | 99.0% | 88.9% |
Deftereos | 63.3 ± 7.0 | 34.7% | 37.8% | 48.5% | 100% | 33.2% | NA | 31.1% | NA | NA | NA |
LoDoCo | 67 ± 9.4 | 11.1% | 4.5% | NA | 30.3% | NA | NA | 23.5% | 93.4% | 95.1% | 66.5% |
ACS, acute coronary syndrome. eGFR, estimated glomerular filtration rate. NA, not available. TIA, transient ischaemic attack. History of stroke or TIA was available for 3318 patients, and smoking status was missing for 21 patients in LoDoCo2.